参考文献/References:
[1]中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.成人社区获得性肺炎基层诊疗指南(实践版2018)[J].中华全科医师杂志,2016,18(2):127-133. [2]中华中医药学会内科分会,中华中医药学会肺系病分会,中国民族医药学会肺病分会.社区获得性肺炎中医诊疗指南(2018修订版)[J].中医杂志,2019,60(4):350-360 [3]郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:356-361. [4]李建生.基于疗效优势的中医治疗社区获得性肺炎切入点的思考[J].中医学报,2017,32(3):345-347. [5]尹鑫,邙光伟,项福星,等.柴胡皂苷及黄酮类化合物药理作用研究[J].园艺与种苗,2018(7):29-31. [6]雷载权.中药学[M].上海:上海科技出版社,2002 [7]代晓光,宋琳.五味子现代药理作用及临床应用研究进展[J].中医药信息,2017,34(5):121-123. [8]李庆耀,梁生林.陈皮的药用研究进展[J].中成药,2008,30(2):247. [9]时登龙,刘代缓,曹喆,等.苦杏仁药理作用及炮制工艺研究进展[J].亚太传统医药,2018,14(12):106-107. [10]王茅,徐祉君,郑文博.甘草的临床运用浅析[J].光明中医,2017,32(11):1669-1671. [11]李明珠.中西医结合治疗社区获得性肺炎54例临床观察[J].中国民族民间医药,2016,25(10):59-60.
相似文献/References:
[1]赵建美,邵 岩.血必净治疗社区获得性肺炎的研究进展[J].医学信息,2018,31(02):20.[doi:10.3969/j.issn.1006-1959.2018.02.009]
ZHAO Jian-mei,SHAO Yan.Research Progress of Xuebijing in Treating Community Acquired Pneumonia[J].Medical Information,2018,31(04):20.[doi:10.3969/j.issn.1006-1959.2018.02.009]
[2]包克珍,许云丽.新生儿社区获得性肺炎的临床特征分析[J].医学信息,2018,31(02):184.[doi:10.3969/j.issn.1006-1959.2018.02.072]
BAO Ke-zhen,XU Yun-li.Clinical Characteristics of Neonatal Community Acquired Pneumonia[J].Medical Information,2018,31(04):184.[doi:10.3969/j.issn.1006-1959.2018.02.072]
[3]赵建美,邵 岩,李京津.电脑中频药透对治疗老年社区获得性肺炎的疗效分析[J].医学信息,2018,31(03):146.[doi:10.3969/j.issn.1006-1959.2018.03.052]
ZHAO Jian-mei,SHAO Yan,LI Jing-jin.Analysis of the Efficacy of Computer Medium Frequency Drug Penetration in the Treatment of Elderly Community-acquired Pneumonia[J].Medical Information,2018,31(04):146.[doi:10.3969/j.issn.1006-1959.2018.03.052]
[4]曹立杰,杨林瀛,于国云,等.N-末端脑钠肽前体与社区获得性肺炎患者严重程度关系研究[J].医学信息,2018,31(04):1.[doi:10.3969/j.issn.1006-1959.2018.04.001]
CAO Li-jie,YANG Lin-ying,YU Guo-yun,et al.Study on the Relationship between N-terminal Brain Natriuretic Peptide Precursors and the Severity of Community-acquired Pneumonia[J].Medical Information,2018,31(04):1.[doi:10.3969/j.issn.1006-1959.2018.04.001]
[5]俞 静,赵 红,金 晶,等.社区获得性肺炎胸部CT中反晕征的初步研究[J].医学信息,2022,35(10):109.[doi:10.3969/j.issn.1006-1959.2022.10.026]
YU Jing,ZHAO Hong,JIN Jing,et al.Preliminary Study of Reversed Halo Sign in Chest CT of Community-acquired Pneumonia[J].Medical Information,2022,35(04):109.[doi:10.3969/j.issn.1006-1959.2022.10.026]
[6]武珊珊.喜炎平注射液治疗社区获得性肺炎临床疗效的Meta分析[J].医学信息,2018,31(14):64.[doi:10.3969/j.issn.1006-1959.2018.14.020]
WU Shan-shan.Meta-analysis of Clinical Efficacy of Xiyanping Injection in the Treatment of
Community-acquired Pneumonia[J].Medical Information,2018,31(04):64.[doi:10.3969/j.issn.1006-1959.2018.14.020]
[7]徐安林,刘 忠.不同配比的哌拉西林-他唑巴坦治疗
老年性社区获得性肺炎的疗效对比[J].医学信息,2018,31(15):129.[doi:10.3969/j.issn.1006-1959.2018.15.041]
XU An-lin,LIU Zhong.Comparison of the Efficacy of Different Ratios of Piperacillin-tazobactam in Elderly Community Acquired Pneumoni[J].Medical Information,2018,31(04):129.[doi:10.3969/j.issn.1006-1959.2018.15.041]
[8]许 俊.慢性阻塞性肺疾病急性加重期与慢性阻塞性肺疾病并发社区获得性肺炎患者的临床对比[J].医学信息,2018,31(22):118.[doi:10.3969/j.issn.1006-1959.2018.22.033]
XU Jun.Clinical Comparison of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Complicated with Community Acquired Pneumonia[J].Medical Information,2018,31(04):118.[doi:10.3969/j.issn.1006-1959.2018.22.033]
[9]远 颖.成人社区获得性肺炎中医药研究[J].医学信息,2018,31(23):55.[doi:10.3969/j.issn.1006-1959.2018.23.016]
YUAN Ying.Traditional Chinese Medicine Research on Adult Community Acquired Pneumonia[J].Medical Information,2018,31(04):55.[doi:10.3969/j.issn.1006-1959.2018.23.016]
[10]陈亚南,陈 赛,毛琦善.青壮年与中老年社区获得性肺炎病原体的对比分析[J].医学信息,2019,32(01):145.[doi:10.3969/j.issn.1006-1959.2019.01.045]
CHEN Ya-nan,CHEN Sai,MAO Qi-shan.Comparative Analysis of Pathogens of Acquired Pneumonia among Young Adults and Middle-aged and Elderly People[J].Medical Information,2019,32(04):145.[doi:10.3969/j.issn.1006-1959.2019.01.045]